RapidAI vs BioKin
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
RapidAI
This medical imaging analysis platform uses AI to help care teams quickly and accurately manage life-threatening conditions. It provides real-time notifications, rapid access to patient imaging, and tools for enhanced care team collaboration to improve patient outcomes.
- AI-driven medical imaging analysis
- Real-time notifications for new cases
- Rapid access to patient imaging (90 seconds)
- DICOM viewer with zoom and rotation
- Care team collaboration tools
- Centralized patient event and results views
Read full descriptionHide full description
RapidAI is the world leader in AI-driven medical imaging analysis and coordinated care. With the industry’s most validated clinical AI platform, we empower care teams to rapidly, precisely, and confidently manage life-threatening conditions. Trusted by thousands of hospitals in 100+ countries, RapidAI delivers the deepest level of clinical decision support on the market to help accelerate the time to treatment and enhance patient outcomes. We go beyond the algorithm to drive care team collaboration and efficiencies that expand access to life-saving interventions. At RapidAI, we establish new standards for care teams and the patients they treat. Physicians save precious time with anywhere, anytime notifications of new patient cases and access to RapidAI results and patient imaging on their mobile device. Rapid Mobile App Features: - Real-time notifications of new case events and messages - Access to RapidAI results and patient images in as few as 90 seconds of a patient scan - Source file viewing through a powerful DICOM viewer - Full screen zoom functionality and landscape mode - Image rotation for axial, coronal and sagittal views - View and organize case results from multiple sites - Flexible configuration options for PHI, biometrics, Single Sign-on and multi-factor authentication - Centralized views of patient events, messages, and results - Fast notification and coordination of stroke teams for critical cases - Simple entry of key clinical information and ability to upload photos to the message feed - In-app calling for quicker communications with stroke team members RapidAI is not for diagnostic decision making. Refer to the PACS or clinical system for case evaluation.
BioKin
Read full descriptionHide full description
BioKin™ Mobile App presents the user interfaces for collecting data from the logger/sensor for sending acquired data and receiving processed scores by the clinician.
Screenshots
Verdict
The clearest difference is update cadence: RapidAI at every 2 weeks against BioKin's every 6 months. BioKin's advantage is iOS requirement (13.0 vs 18.0). On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
RapidAI ships an update every 2 weeks, BioKin every 6 months. The most recent releases landed on November 18, 2026 and November 3, 2026 respectively.
| Parameter | RapidAI | BioKin |
|---|---|---|
| Price | Free | Free |
| Rating | 4.0 (13 ratings) — better | — |
| Positive reviews | 42.9% of reviews | — |
| Number of ratings | 13 — better | — |
| Update frequency | Every 2 weeks — better | Every 6 months |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad | iPhone, iPad, iPod — better |
| Requires iOS | 18.0 | 13.0 — better |
| Further details — not scored | ||
| Size | 125 MB | 54 MB |
| Age rating | 17+ | 12+ |
| Developer | iSchemaView | Srinivas Shesham |
In-app purchases
RapidAI
No in-app purchases
BioKin
No in-app purchases








